OTC · TXTM
ProText Mobility, Inc.
$0.01+$0.00 (+6.67%)
ProText Mobility, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
Loading market information…
OTC · MYNDF · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
MYND Life Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
MYND Life Sciences Inc. operates as a neuro-pharmaceutical company, applying life science principles to develop innovative treatments for depressive conditions. The firm conducts scientific research and clinical trials in Canada and the United States, concentrating on therapeutic compounds that possess neuro-anti-inflammatory properties. A significant part of its research involves the in-depth study of psilocin and psilocybin extracts, along with their various analogs. The company's principal office is situated in Kelowna, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01+$0.00 (+6.67%)
ProText Mobility, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
CA$0.04CA$0.00 (0.0%)
Glow Lifetech Corp.’s quoted price sits in the lower half of its reported 52-week range, 38.46% below the high.
CA$0.04CA$0.00 (0.0%)
Kane Biotech Inc.’s quoted price sits in the upper half of its reported 52-week range, 30.0% below the high.
$0.09$0.00 (0.0%)
BioVaxys Technology Corp.’s quoted price sits in the lower half of its reported 52-week range, 56.73% below the high.
$0.02+$0.00 (+1.36%)
Bioxytran, Inc.’s quoted price sits in the lower half of its reported 52-week range, 78.42% below the high.
$0.14$0.00 (0.0%)
Mosaic ImmunoEngineering Inc.’s quoted price sits in the lower half of its reported 52-week range, 84.61% below the high.
£0.00-£0.00 (-0.53%)
Futura Medical plc’s quoted price sits in the lower half of its reported 52-week range, 93.29% below the high.
$0.00$0.00 (0.0%)
Theralink Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
